Outcomes summary

Randomized trial comparing tirzepatide versus semaglutide for weight management in adults with obesity; tirzepatide achieved greater mean weight loss, with gastrointestinal adverse events common in both groups.

Notes

Primary source: PMID 40353578 (see PubMed link on this page).